Beiersdorf Ag

National Institutes of Health, a Component of the US Dept. of Health & Human Services

Ludger Kolbe

Stefan Biel

Andreas Bleckmann

Rainer Wolber

Cathrin Scherner

Christopher Mummert

Thomas Raschke

Anja Göppel

Claudia Mundt

Jan Batzer

Tobias Mann

Anette Bürger

Julia Eckert

Stephan Ruppert

Franz Stäb

Karen Tom Dieck

Anja Aechtner

Vincent J Hearing

Rainer Kröpke

Karl-Heinz Woeller

Michael Woehrmann

Isabel Balcke

Alexander Filbry

Uta Meiring

Ursula Wensorra

Thomas Blatt

Albrecht Doerschner

Jörg Schreiber

Torsten Schlaeger

Volker Achterberg

Svea Behrens

Kerstin Eggers

Helga Biergiesser

Harald Albrecht

Gitta Neufang

Stefanie Knaupmeier

Olga Reichert

Jörg Kuether

Maren Wilken

Dennis Roggenkamp

Sabrina Breitkreutz

Wolfram Gerwat

Ursula Wennsorra

Wonseon Choi

Christian Dingler

Svenja Cerv

Dorthe Lüdemann

Holger Lenz

Maike Kuhlmann

Christoph Mummert

Michael Hong

Jeannine Immeyer

Helge Schwengler

Maren Meyer

Sabrina Ahlheit

Michael Wöhrmann

Karl-Heinz Wöller

Stefanie HÖLTKEMEIER

Michael WÖHRMANN

Torsten SCHLÄGER

Ingo Hahn

Jessica Rathsack

The present invention is a cosmetic or dermatological preparation comprising 0.01% by weight to 5% by weight of at least one red light-filtering dye and 0.0001% by weight to 10% by weight of at least one anti-inflammatory active ingredient. The preparation can be used for the prophylaxis and treatment of sun-irritated skin and to aid the body's own repair mechanisms.

Cosmetic or dermatological preparation comprising a combination of a dye and an anti-inflammatory active ingredient

The present invention relates to preparations, particularly cosmetic and dermatological preparations, comprising aextract. In one embodiment, the extract includes licochalcone A. The preparations are useful for the treatment or prevention of rosacea. The invention also relates to methods of treating or preventing rosacea comprising applyingextract, particularly including licochalcone A. In one embodiment, theextract is part of a cosmetic or dermatological preparation.

Use of licochalcone a for treatment of rosacea

Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis and treatment of sensitive skin, itching, dry skin, and of inflammatory states of the human skin.

Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin

Licochalcone A and/or plant extracts or microbiologically obtained extracts with an active content of Licochalcone A or cosmetic or dermatological preparations containing Licochalcone A and/or plant extracts or microbiologically obtained extracts with an active content of Licochalcone A for the care of the skin of patients of diabetes mellitus.

Active substances and cosmetic or dermatological preparations containing said active substances for the care of the skin of patients of diabetes mellitus

Transdermal therapeutic systems that contain 4-n-butylresorcinol as an active ingredient.

Transdermal therapeutic patches containing 4-N-butylresorcinol

Disclosed are active ingredient combinations of alkylamidothiazoles and one or more cosmetically or dermatologically acceptable preservatives.

Combinations of alkylamidothiazoles and preservatives

Alkylamidothiazoles of general formula (I), wherein R 1=&#x2014;C1-C24 alkyl (linear and branched), &#x2014;C1-C24 alkenyl (linear and branched), &#x2014;C1-C8 cycloalkyl, &#x2014;C1-C8 cycloalkyl-alkylhydroxy, &#x2014;C1-C24 alkylhydroxy (linear and branched), &#x2014;C1-C24 alkylamine (linear and branched), &#x2014;C1-C24 alkylaryl (linear and branched), &#x2014;C1-C24 alkylaryl-alkyl-hydroxy (linear and branched), &#x2014;C1-C24 alkyl-heteroaryl (linear and branched), &#x2014;C1-C24-alkyl-O&#x2014;C1-C24-alkyl (linear and branched), &#x2014;C1-C24 alkyl morpholino, &#x2014;C1-C24 alkyl piperidino, &#x2014;C1-C24 alkyl piperazino, &#x2014;C1-C24 alkyl-piperazino-N-alkyl, as well as cosmetic or dermatological preparations having an effective content of one or more alkylamidothiazoles, as well as the use thereof for the cosmetic or dermatological treatment and/or prophylaxis of undesired skin pigmentation. 

Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin

Disclosed herein are compositions and methods of using such compositions to modulate pigmentation and proliferation of a melanocyte, such as to prevent or treat skin disorders, including skin cancer or for use for cosmetic purposes. In one example, a method of modulating pigmentation of a melanocyte includes contacting the melanocyte (such as a human melanocyte) with an agent that modulates neuregulin-1 (NRG-1) activity, such as an agent that increases or decreases NRG-1 activity, thereby modulating pigmentation of the melanocyte. In one particular example, the method of increasing melanocyte pigmentation or proliferation can be used to reduce UV skin damage, including that associated with skin cancer. In another example, the method of decreasing melanocyte pigmentation can be used to treat a skin pigmentation disorder associated with undesired increased skin pigmentation.

Regulation of skin pigmentation by neuregulin-1 (NRG-1)

Disclosed are cosmetic or dermatological preparations for the treatment or alleviation of erythema which comprise an aqueous extract of Radix Glycyrrhizae inflatae or licochalcone A and optionally one or more ethoxylated or propoxylated raw materials and/or one or more polyols.

Cosmetic or dermatological preparations containing licochalcone A or an extract of radix glycyrrhizae inflatae, containing licochalcone A

Cosmetic or dermatological preparations having an effective content of one or more thiazoles of the general formula. 

Cosmetic or dermatological preparations with a content of one or more thiazole derivates

Cosmetic hair- and/or body-cleansing compositions comprising licochalcone A or an extract of Radixand one or more surfactants and, optionally, further comprising cosmetic and/or dermatological active ingredients, auxiliaries and additives.

Surfactant-containing preparation comprising licochalcone A

Cosmetic or dermatological preparations with a content of an aqueous extract ofor licochalcone A, one or more ethoxylated or propoxylated raw materials, optionally one or more polyols.

[object Object]

A topical cosmetic and dermatological preparation for reducing skin reddening which comprises (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)&#x2014;N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide.

Cooling cosmetic or dermatological preparations comprising (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)-cyclohexane carboxamide and/or (1R,2S,5R)-N-(4-cyanomethyl-phenyl)-2-isopropyl-5-methylcyclohexane carboxamide for reducing skin reddening

Post-foaming cosmetic cleansing preparation on an aqueous basis which is suitable for dispensing from an aerosol container, containing in a conventional aqueous base preparation a) detersive surfactants with saturated radicals, preferably anionic surfactants and non-ionic surfactants and/or amphoteric surfactants, b) 2.5 to 25% by volume, preferably 5 to 20% by volume, particularly preferably 7.5 to 15% by volume of pure oxygen.

Post-foaming cleansing product with molecular oxygen

The present invention relates to the use of licochalcone A for the treatment of rosacea.

Use of licochalcone A against rosacea

Growing community of inventors

Dohren, Germany

Ludger Kolbe